本文轉載至原廠電子報:Biorbyt  原廠電子報

The latest know-how from Biorbyt.




Fibroblast Growth Factor Receptors


Fibroblast Growth Factor Receptors


Fibroblast Growth Factor Receptors (FGFRs) are a family of FGF-binding transmembrane receptors involved in regulating cell growth and proliferation, angiogenesis, and numerous developmental processes. They are highly conserved, consisting of three extracellular immunoglobulin-type domains, IgI, IgII, and IgIII, which enable ligand binding, a transmembrane domain, and an intracellular tyrosine kinase domain which exerts its downstream signaling effects. The signaling pathway activated by FGFR/FGF has been implicated in several cancers; consequently, FGFR inhibitors are being investigated as potential therapeutic agents in many cancer studies.




Peptide biomarkers predicts severity


Biorbyt now offer unique tailored biomarker tests for COVID-19.

The test classifies and predicts COVID-19 disease severity, based on host response to COVID-19.

The test predicts whether COVID-19 patients:

  1. are likely to develop severe disease (WHO 3 vs WHO 4-7);
  2. will need invasive ventilation;
  3. are likely to survive if they have severe disease.

The purpose of the biomarker test is to demonstrate treatment efficacy, elucidate the MoA of COVID-19 therapeutics in development and to provide a readout of what the disease would have looked like without treatment.




Resources for you


Hi Jimmy, here’s a selection of resources to help with your research.



Our mission is to help with your research





© 2021 Biorbyt Ltd. All Rights Reserved.

5 Orwell Furlong, Cowley Road, Cambridge. CB4 0WY.





LINE 線上諮詢



error: Content is protected !!